bfkb8488a
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 29, 2015 (NCT02593331)
Timeline
Indications
Mechanism of action
- Fibroblast growth factor receptor 1INHIBITOR
FGFR1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bfkb8488a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04171765 | Phase 2 | Nov 27, 2019 | Genentech, Roche |
| NCT03060538 | Phase 1 | Feb 6, 2017 | Genentech, Roche |
| NCT02593331 | Phase 1 | Oct 29, 2015 | Genentech, Roche |
Showing 3 of 3 trials
Page 1 / 1